Enasidenib mesylate, 5mg

Enasidenib mesylate (AG-221 mesylate) is a potent and selective IDH2 mutant enzyme inhibitor that promotes the differentiation of leukemia myeloblasts and can be used in the treatment of acute myeloid leukemia.

• Size: 5mg
• Purity: ≥98%
• Molecular Formula: C 2 0 H 2 1 F 6 N 7 O 4 S
• Molecular Weight: 569.48
• Physical State: White to off-white Solid
• Storage: Powder:2-8℃, 2 years;Insolvent(mother liquid):-20℃, 6 months;-80℃, 1 year
• Brand: Saint Michael
• Catalogue No.: IE3570-5mg

For laboratory research use only. Not for human or animal consumption, diagnostic or therapeutic use.